Mason Michael
Insider CIK 1514291 · ALNY VP, Finance and Tresurer · KPTI SVP, CFO & Treasurer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KPTI Karyopharm Therapeutics In | S Sale | 2024-09-04 | 2024-09-05 | 7,050 | $0.72 | $5.1K | 391,054 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-06-04 | 2024-06-06 | 652 | $0.99 | $645 | 398,104 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-03-01 | 2024-03-04 | 6,162 | $1.20 | $7.4K | 398,756 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-29 | 2024-03-04 | 27,687 | $1.17 | $32.4K | 404,918 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2024-02-28 | 2024-02-29 | 188,205 | — | $0 | 432,605 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-27 | 2024-02-29 | 2,545 | $1.32 | $3.4K | 244,400 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2024-02-06 | 2024-02-08 | 4,205 | $1.59 | $6.7K | 246,945 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2024-01-24 | 2024-01-25 | 13,333 | — | $0 | 251,150 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-09-01 | 2023-09-05 | 6,913 | $1.33 | $9.2K | 237,817 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-06-02 | 2023-06-05 | 631 | $2.22 | $1.4K | 244,730 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-03-01 | 2023-03-02 | 11,205 | $3.03 | $34.0K | 245,361 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2023-02-28 | 2023-03-02 | 95,000 | — | $0 | 256,566 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-02-27 | 2023-03-01 | 2,802 | $3.04 | $8.5K | 161,566 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2023-02-06 | 2023-02-08 | 4,141 | $3.40 | $14.1K | 164,368 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-08-31 | 2022-09-01 | 45,000 | — | $0 | 45,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2022-08-31 | 2022-09-01 | 30,000 | — | $0 | 168,509 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-03 | 2022-06-06 | 598 | $6.04 | $3.6K | 138,512 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-06-03 | 2022-06-06 | 3 | $6.07 | $18 | 138,509 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2022-02-28 | 2022-03-02 | 111,600 | — | $0 | 111,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2022-02-28 | 2022-03-02 | 88,200 | — | $0 | 141,508 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-28 | 2022-03-02 | 2,398 | $10.24 | $24.6K | 139,110 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2022-02-07 | 2022-02-09 | 3,947 | $9.86 | $38.9K | 53,308 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-06-01 | 2021-06-01 | 15,000 | — | $0 | 15,000 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2021-06-01 | 2021-06-01 | 5,500 | — | $0 | 57,255 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2021-02-25 | 2021-03-01 | 59,968 | — | $0 | 59,968 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award | 2021-02-25 | 2021-03-01 | 22,013 | — | $0 | 51,755 | SEC↗ |
| KPTI Karyopharm Therapeutics In | S Sale | 2021-02-11 | 2021-02-17 | 2,858 | $15.52 | $44.4K | 5,292 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise deriv | 2021-02-05 | 2021-02-09 | 8,150 | — | $0 | 24,450 | SEC↗ |
| KPTI Karyopharm Therapeutics In | M Exercise | 2021-02-05 | 2021-02-09 | 8,150 | — | $0 | 8,150 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 32,600 | — | $0 | 32,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2020-02-05 | 2020-02-07 | 87,600 | — | $0 | 87,600 | SEC↗ |
| KPTI Karyopharm Therapeutics In | A Award deriv | 2019-02-25 | 2019-02-25 | 150,000 | — | $0 | 150,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 1,387 | — | $0 | 2,775 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-09-27 | 2018-09-28 | 1,800 | — | $0 | 5,400 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-21 | 2018-08-23 | 1,800 | — | $0 | 3,600 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2018-08-13 | 2018-08-14 | 449 | $90.95 | $40.8K | 563 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2018-08-13 | 2018-08-14 | 1,012 | — | $0 | 1,012 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 2,750 | — | $0 | 2,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-08-10 | 2018-08-14 | 1,666 | — | $0 | 1,666 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-07-10 | 2018-08-14 | 23 | — | $0 | 276 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-04-16 | 2018-08-14 | 22 | — | $0 | 253 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2018-03-01 | 2018-03-05 | 4,000 | — | $0 | 4,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | J Other | 2018-01-17 | 2018-08-14 | 5 | — | $0 | 231 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 2,750 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 1,667 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 2,750 | — | $0 | 2,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 10,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 6,187 | — | $0 | 2,063 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 3,600 | — | $0 | 3,600 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 3,439 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2018-01-04 | 2018-01-08 | 1,388 | — | $0 | 4,162 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-01-04 | 2018-01-08 | 12,405 | $132.18 | $1.64M | 2,591 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-01-04 | 2018-01-08 | 1,591 | $132.98 | $211.6K | 1,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-01-04 | 2018-01-08 | 400 | $133.83 | $53.5K | 600 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-01-04 | 2018-01-08 | 600 | $135.00 | $81.0K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 1,667 | $63.00 | $105.0K | 8,019 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 1,388 | $42.22 | $58.6K | 6,352 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-01-04 | 2018-01-08 | 16,500 | $131.20 | $2.16M | 14,996 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2018-01-04 | 2018-01-08 | 5,249 | $130.42 | $684.6K | 31,496 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 3,439 | $63.00 | $216.7K | 36,745 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 6,187 | $96.45 | $596.7K | 33,306 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 10,000 | $97.72 | $977.2K | 27,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 2,750 | $96.45 | $265.2K | 17,119 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 2,750 | $96.45 | $265.2K | 14,369 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2018-01-04 | 2018-01-08 | 3,600 | $88.95 | $320.2K | 11,619 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-12-30 | 2018-01-03 | 8,502 | — | $0 | 0 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-12-30 | 2018-01-03 | 8,502 | — | $0 | 8,502 | SEC↗ |
| ALKS ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2017-12-30 | 2018-01-03 | 3,538 | $127.05 | $449.5K | 4,964 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-12-20 | 2017-12-21 | 1,388 | — | $0 | 1,388 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-11-06 | 2017-11-08 | 1,800 | — | $0 | 1,800 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-09-20 | 2017-09-22 | 1,667 | — | $0 | 1,667 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2017-07-07 | 2017-07-11 | 2,750 | — | $0 | 5,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-05-16 | 2017-05-17 | 3,750 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2017-05-16 | 2017-05-17 | 5,625 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2017-05-16 | 2017-05-17 | 9,375 | $70.00 | $656.3K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-05-16 | 2017-05-17 | 5,625 | $18.66 | $105.0K | 5,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2017-05-16 | 2017-05-17 | 3,750 | $7.10 | $26.6K | 9,375 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-12-30 | 2017-01-03 | 8,502 | — | $0 | 8,502 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-12-20 | 2016-12-22 | 5,550 | — | $0 | 5,550 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2016-02-01 | 2016-02-03 | 2,750 | — | $0 | 2,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-18 | 2015-12-22 | 7,200 | — | $0 | 7,200 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-12-07 | 2015-12-09 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-06-01 | 2015-06-03 | 1,524 | — | $0 | 3,439 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-06-01 | 2015-06-03 | 1,667 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-06-01 | 2015-06-03 | 1,563 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2015-06-01 | 2015-06-03 | 37 | — | $0 | 4,963 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-06-01 | 2015-06-03 | 37 | $63.00 | $2.3K | 1,600 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-01 | 2015-06-03 | 200 | $133.12 | $26.6K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-01 | 2015-06-03 | 2,064 | $132.49 | $273.5K | 200 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-01 | 2015-06-03 | 1,767 | $131.56 | $232.5K | 2,264 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-06-01 | 2015-06-03 | 1,524 | $63.00 | $96.0K | 3,124 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-06-01 | 2015-06-03 | 1,667 | $63.00 | $105.0K | 4,791 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2015-06-01 | 2015-06-03 | 760 | $130.39 | $99.1K | 4,031 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2015-06-01 | 2015-06-03 | 1,563 | $10.98 | $17.2K | 1,563 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2015-05-01 | 2015-05-05 | 8,250 | — | $0 | 8,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-15 | 2014-12-16 | 4,563 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-15 | 2014-12-16 | 7,937 | — | $0 | 1,563 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-15 | 2014-12-16 | 3,750 | — | $0 | 3,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2014-12-15 | 2014-12-16 | 4,375 | — | $0 | 5,625 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-15 | 2014-12-16 | 7,937 | $10.98 | $87.1K | 14,037 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-15 | 2014-12-16 | 4,563 | $9.14 | $41.7K | 6,100 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-15 | 2014-12-16 | 3,750 | $7.10 | $26.6K | 17,787 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2014-12-15 | 2014-12-16 | 4,375 | $18.66 | $81.6K | 22,162 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 8,704 | $95.10 | $827.8K | 13,458 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 4,128 | $95.97 | $396.2K | 9,330 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 820 | $103.60 | $85.0K | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 900 | $102.56 | $92.3K | 820 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 2,000 | $101.75 | $203.5K | 1,720 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 1,835 | $100.52 | $184.5K | 3,720 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 1,475 | $99.73 | $147.1K | 5,555 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 900 | $98.48 | $88.6K | 7,030 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-12-15 | 2014-12-16 | 1,400 | $97.12 | $136.0K | 7,930 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2014-12-12 | 2014-12-16 | 1,667 | — | $0 | 1,667 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-02-03 | 2014-02-04 | 2,110 | $79.04 | $166.8K | 1,637 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-02-03 | 2014-02-04 | 1,540 | $78.08 | $120.2K | 3,747 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2014-02-03 | 2014-02-04 | 100 | $79.74 | $8.0K | 1,537 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | F Tax w/h | 2014-01-23 | 2014-01-27 | 2,560 | $89.49 | $229.1K | 5,287 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2013-12-18 | 2013-12-18 | 5,000 | — | $0 | 5,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-16 | 2013-12-18 | 2,000 | — | $0 | 4,563 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-16 | 2013-12-18 | 3,000 | — | $0 | 9,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-16 | 2013-12-18 | 3,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-16 | 2013-12-18 | 3,000 | $16.43 | $49.3K | 15,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-16 | 2013-12-18 | 5,800 | $60.20 | $349.2K | 10,047 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-16 | 2013-12-18 | 2,200 | $60.77 | $133.7K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-16 | 2013-12-18 | 3,000 | $10.98 | $32.9K | 12,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-16 | 2013-12-18 | 2,000 | $9.14 | $18.3K | 9,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-12-02 | 2013-12-04 | 3,750 | — | $0 | 7,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-12-02 | 2013-12-04 | 3,750 | $7.10 | $26.6K | 11,597 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-02 | 2013-12-04 | 1,905 | $61.55 | $117.3K | 9,692 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-12-02 | 2013-12-04 | 1,845 | $62.12 | $114.6K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-07-12 | 2013-07-12 | 14,200 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-07-12 | 2013-07-12 | 14,200 | $31.39 | $445.7K | 22,047 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-07-12 | 2013-07-12 | 14,200 | $50.00 | $710.0K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-07-01 | 2013-07-02 | 15,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-07-01 | 2013-07-02 | 12,000 | — | $0 | 0 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-07-01 | 2013-07-02 | 15,000 | $32.00 | $480.0K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-07-01 | 2013-07-02 | 12,000 | $21.35 | $256.2K | 19,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-07-01 | 2013-07-02 | 12,000 | $32.00 | $384.0K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-07-01 | 2013-07-02 | 15,000 | $22.75 | $341.3K | 22,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-06-17 | 2013-06-19 | 4,375 | — | $0 | 6,563 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-06-17 | 2013-06-19 | 13,000 | — | $0 | 3,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2013-06-17 | 2013-06-19 | 6,250 | — | $0 | 12,500 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-06-17 | 2013-06-19 | 6,250 | $29.93 | $187.1K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-06-17 | 2013-06-19 | 13,000 | $29.93 | $389.1K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-06-17 | 2013-06-19 | 13,000 | $16.43 | $213.6K | 20,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-06-17 | 2013-06-19 | 4,375 | $9.14 | $40.0K | 12,222 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2013-06-17 | 2013-06-19 | 6,250 | $10.98 | $68.6K | 14,097 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2013-06-17 | 2013-06-19 | 4,375 | $29.93 | $130.9K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award deriv | 2012-12-20 | 2012-12-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2012-11-30 | 2012-12-04 | 3,750 | — | $0 | 11,250 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2012-11-30 | 2012-12-04 | 3,750 | $16.93 | $63.5K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2012-11-30 | 2012-12-04 | 3,750 | $7.10 | $26.6K | 11,597 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2012-07-27 | 2012-07-31 | 6,250 | — | $0 | 18,750 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2012-07-27 | 2012-07-31 | 6,250 | $10.98 | $68.6K | 14,097 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2012-07-27 | 2012-07-31 | 6,250 | $20.00 | $125.0K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2012-07-16 | 2012-07-18 | 6,562 | — | $0 | 10,938 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise deriv | 2012-07-16 | 2012-07-18 | 8,733 | — | $0 | 8,767 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2012-07-16 | 2012-07-18 | 8,733 | $19.00 | $165.9K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | S Sale | 2012-07-16 | 2012-07-18 | 6,562 | $18.00 | $118.1K | 7,847 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2012-07-16 | 2012-07-18 | 6,562 | $9.14 | $60.0K | 14,409 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | M Exercise | 2012-07-16 | 2012-07-18 | 8,733 | $13.12 | $114.6K | 16,580 | SEC↗ |
| ALNY ALNYLAM PHARMACEUTICALS, I | A Award | 2012-01-23 | 2012-01-25 | 7,847 | — | $0 | 7,847 | SEC↗ |